Ignite Creation Date:
2025-12-25 @ 4:17 AM
Ignite Modification Date:
2025-12-26 @ 3:17 AM
Study NCT ID:
NCT04364620
Status:
COMPLETED
Last Update Posted:
2025-04-06
First Post:
2020-04-23
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
AB-16B5 Combined With Docetaxel in Subjects With Metastatic Non-Small Cell Lung Cancer (EGIA-002)
Sponsor:
Alethia Biotherapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-02-23
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-12-31
Completion Date Type:
ACTUAL
First Submit Date:
2020-04-23
First Submit QC Date:
None
Study First Post Date:
2020-04-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-01-31
Results First Submit QC Date:
None
Results First Post Date:
2025-04-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-04
Last Update Post Date:
2025-04-06
Last Update Post Date Type:
ACTUAL